|
|
Article: Prostate drug: good and mostly bad news.
- Article from:
- HealthFacts
- Article date:
- July 1, 2003
CopyrightCOPYRIGHT 2003 Center for Medical Consumers, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
When Proscar was first approved to treat the symptoms of an enlarged prostate, the drug was thought to have cancer prevention possibilities. Last month, the online version of The New England Journal of Medicine published good news/bad news results from the Prostate Cancer Prevention Trial involving 18,000 healthy men, aged 55 years and older. All the participants were at low risk for developing prostate cancer; they had been randomly assigned to take daily doses of either Proscar or a placebo for seven years. The researchers found that taking Proscar lowered the odds of getting prostate cancer but raised the likelihood of developing an aggressive form of the disease. ...
Related newspaper, magazine, and journal articles:
|
|
Article: Update diet and prostate cancer ...
Environmental Nutrition;
September 1, 2009 ;
700+ words
... ... therapies in prostate cancer prevention were reviewed ... efficacy for prostate cancer prevention. Some trials ... shown it reduces prostate cancer risk. However ... and Vitamin E Cancer Prevention Trial (SELECT ...
|
|